Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD34+ Stem Cells”

229 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 229 results

Testing effectiveness (Phase 2)Study completedNCT01105403
What this trial is testing

Exploratory Study on POL6326 in Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Polyphor Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Not applicableAvailableNCT06731036
What this trial is testing

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Who this might be right for
Severe Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more
University of Florida
Large-scale testing (Phase 3)Study completedNCT00551928
What this trial is testing

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaNewly Diagnosed Patients
Fondazione EMN Italy Onlus 402
Testing effectiveness (Phase 2)Study completedNCT01596257
What this trial is testing

Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation

Who this might be right for
Leukemia
Memorial Sloan Kettering Cancer Center 116
Large-scale testing (Phase 3)Study completedNCT01767714
What this trial is testing

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

Who this might be right for
Non-Hodgkin's Lymphoma
Sanofi 100
Not applicableLooking for participantsNCT07604467
What this trial is testing

The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome

Who this might be right for
Tako Tsubo CardiomyopathyMicrovascular DysfunctionCD34+ Stem Cells+2 more
University Medical Centre Ljubljana 40
Early research (Phase 1)Study completedNCT02800070
What this trial is testing

Autologous Stem Cell Transplantation of Cells Engineered to Express Alpha-Galactosidase A in Patients With Fabry Disease

Who this might be right for
Fabry Disease
University Health Network, Toronto 5
Early research (Phase 1)Temporarily pausedNCT01504594
What this trial is testing

Autologous Stem Cells in Pediatric Patients With Dilated Cardiomyopathy

Who this might be right for
Cardiomyopathy, Dilated
Hospital Universitario Dr. Jose E. Gonzalez 10
Testing effectiveness (Phase 2)Ended earlyNCT00450983
What this trial is testing

Donor Peripheral Stem Cell Transplant and Donor Natural Killer Cell Transplant After Total-Body Irradiation, Thiotepa, Fludarabine, and Muromonab-CD3 in Treating Patients With Leukemia or Other Blood Diseases

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center 1
Testing effectiveness (Phase 2)Ended earlyNCT06716853
What this trial is testing

A Clinical Gene Therapy Study With Hematopoietic Stem Cells for the Treatment, With Single Dose of Temferon, of Patients Suffering From Metastatic Renal Cell Carcinoma

Who this might be right for
Clear Cell RCC
Genenta Science 10
Testing effectiveness (Phase 2)Study completedNCT03384420
What this trial is testing

Evaluate the Safety and Therapeutic Effects of Transplantation of MNV-BM-BLD in Pediatric Patients With Pearson Syndrome

Who this might be right for
Mitochondrial DiseasesPearson Syndrome
Minovia Therapeutics Ltd. 7
Testing effectiveness (Phase 2)Study completedNCT01351610
What this trial is testing

Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia

Who this might be right for
Critical Limb IschemiaPeripheral Artery Disease
Apceth GmbH & Co. KG 25
Testing effectiveness (Phase 2)Study completedNCT00950521
What this trial is testing

Efficacy Study of CD34 Stem Cell in Chronic Stroke Patients

Who this might be right for
StrokeMiddle Cerebral Artery Infarction
China Medical University Hospital 30
Testing effectiveness (Phase 2)Ended earlyNCT04635735
What this trial is testing

Study of Ipilimumab After Stem Cell Transplantation in People With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center 3
Early research (Phase 1)Study completedNCT00004904
What this trial is testing

Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Northwestern University
Testing effectiveness (Phase 2)Ended earlyNCT03875495
What this trial is testing

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)

Who this might be right for
Multiple Myeloma
Genenta Science 9
Early research (Phase 1)Study completedNCT00197522
What this trial is testing

Administration of Autologous Dendritic Cells (DCs) Infected With an Adenovirus Expressing Her-2

Who this might be right for
Breast Neoplasms
Hamilton Health Sciences Corporation 5
Not applicableLooking for participantsNCT05773729
What this trial is testing

Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia

Who this might be right for
β-thalassemia
Shanghai BDgene Co., Ltd. 10
Large-scale testing (Phase 3)Study completedNCT02454231
What this trial is testing

Monocentric Trial: Stem Cell Emergency Life Threatening Limbs Arteriopathy (SCELTA)

Who this might be right for
Critical Limb Ischemia
University of Florence 45
Next Page